Solera Health, an integrated benefit network, and WellDoc, a leading digital therapeutic company has announced that WellDoc’s BlueStar® digital therapeutic will join the Solera network as a diabetes management solution of choice. The integration partnership aligns both companies’ goals to improve the lives of those living with chronic diseases while enhancing clinical results and decreasing overall healthcare costs.Solera Health connects patients, payers and physicians with community
Read More
Impact of Diabetes Management for Patients, Payers, and Providers| News, Policy, Analysis, Insights - HIT Consultant
Livongo, Lilly Team Up on Real-World Diabetes Research
Eli Lilly and Companyand Livongo Health, a consumer digital health company focused on empowering all people with chronic conditions to live better and healthier lives has teamed up on a new strategic collaboration to study real-world evidence and develop new insights to reduce the burden on people living with diabetes.The research collaboration will combine real-world behavioral studies and claims data to advance knowledge about effective interventions in diabetes care. The companies aim to
Read More
Livongo Launches Digital Diabetes Management Platform for 4,000 Alaskans
.Livongo, a consumer digital health company has teamed up with Medical Park Family Care, the largest primary care group in Alaska to launch Livongo for Diabetes platform to 4,000 people with diabetes receiving care from Medical Park Family Care. The partnership will enable providers to recommend Livongo’s digital health platform, alongside diabetes prescriptions, regular primary care appointments, and clinic services, to ensure that people with diabetes receive 24/7 ongoing support and tools to
Read More
Innovation Health Launches Types 2 Diabetes Pilot Program With Sanofi
Innovation Health, an innovation partnership between Inova and Aetna has announced a new pilot program with Sanofi for people living with Type 2 diabetes. The focus of the pilot program will work to study the impact of novel digital helath solutions from One Drop and Gocap to help patient outcomes and medication adherence. The pilot program will be facilitated by Innovation Health, Inova Health Systems and Healthagen, a division of Aetna. Digital Therapeutic Pilot Program OverviewThe goal of the
Read More
Novo Nordisk & Glooko Launch Integrated Diabetes Management App
Novo Nordisk and Glooko has announced the launch of their new integrated diabetes management app, Cornerstones4Care (C4C app) for patients. The C4C mobile app integrates Novo Nordisk's extensive knowledge of diabetes and personalized patient support with Glooko's digital platform and data analytics expertise. Cornerstones4Care Powered by Glooko AppThe integrated app concept will initially enable people with diabetes to easily measure and track their blood glucose, activity and meals all in one
Read More
Solera Health Raises $18.3M to Expand Integrated Chronic Disease Prevention Services
Solera Health, a technology-enabled personalized preventive health network has raised $18.3 million in Series B funding led by Adams Street Partners. Existing strategic investors Blue Cross Blue Shield Venture Partners, Sandbox Industries and social impact fund SJF Ventures also participated in the round. The latest round brings the company’s total capital raised to $30.3 million.Solera plans to use the funding to meet market demand for the Medicare DPP benefit in addition to expanding its
Read More
Roche Acquires Mobile Diabetes Management Platform mySugr
Roche has acquired mobile diabetes management platform mySugr to form a leading open platform for digital diabetes management. For Roche, the acquisition will allow the company to expand its position in the diabetes management market.As part of the acquisition, mySugr will remain as a separate legal entity with an open platform for all diabetes devices and services. Users will continue to have the ability to automatically upload blood glucose data from their preferred device into the mySugr
Read More
Glooko Raises $35M to Expand Diabetes Data Platform Internationally
Glooko, a Mountain View, CA-based provider of diabetes data management has rasied $35 million in Series C funding led by Georgian Partners with participation from Insulet Corporation, Mayo Clinic, Canaan Partners, Social Capital, Medtronic and Samsung NEXT. The company plans to use the funding to expand its’ commercialization efforts in France, Germany, the U.K., Asia and the Middle East, and further development efforts in data analytics and artificial intelligence to provide personalized
Read More
Medtronic, Aetna Form Outcomes-Based Partnership for Diabetic Patients
Medtronic, a medical technology provider has entered into a new outcomes-based, risk-sharing agreement with Aetna for type 1 and type 2 diabetes patients currently on multiple daily insulin injections for their diabetes management. The agreement will measure health outcomes for a patient with diabetes who transition to Medtronic’s insulin pump therapy that constantly self-adjusts to keep patients’ blood sugar levels in range based on their personalized needs.This outcomes-based, risk-sharing
Read More
Study: Glooko’s Diabetes Mobile App Improved Glucose & A1C Rates
Diabetes data management company Glooko announced that its mobile app was associated with a drop in average blood glucose, estimated A1C (eA1C) and hyperglycemia rates in people with diabetes, according to results of two retrospective studies. Furthermore, usage of the Glooko mobile app was also associated with an increase in blood glucose test rate. Increased blood glucose testing rates have been shown to directly correlate with improvements in glycemic control, as evidenced by this
Read More
